Semaglutide is a prime example of groundbreaking medical research in the field of diabetes treatment. It is an injectable medication that has encapsulated the diabetes drug in a tablet form. The United States FDA approved Semaglutide medication in 2019 under the brand name Rybelsus. Clinical studies show that it is highly effective in controlling blood sugar levels in patients with type 2 diabetes.
At Ningbo Excellent New Material Co., Ltd., we are proud to be at the forefront of manufacturing and supplying Semaglutide (Rybelsus) tablets to healthcare facilities worldwide. Our company has a long-standing reputation for producing high-quality medical-grade products that meet the stringent quality standards demanded by the industry.
Our team of researchers and technicians is well-versed in the manufacturing of semaglutide-based medication and ensures that each tablet is of premium quality. Additionally, we provide customized drug development solutions from classical synthetic chemistry through to high-throughput purification and screening. Contact Ningbo Excellent New Material Co., Ltd., China's leading supplier, manufacturer, and factory of semaglutide today and let us help improve the lives of people living with type 2 diabetes.